AMRS:NSD-Amyris Inc (USD)

COMMON STOCK | Specialty Chemicals | NSD

Last Closing Price

USD 4.21

Change

-0.38 (-8.28)%

Market Cap

USD 1.29B

Volume

7.28M

Avg Analyst Target

USD 22.40 (+432.07%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Amyris Inc (AMRS) Stock Analysis:
Based on the Amyris Inc stock forecasts from 4 analysts, the average analyst target price for Amyris Inc is USD 22.40 over the next 12 months. Amyris Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Amyris Inc is Slightly Bullish , which is based on 3 positive signals and 2 negative signals. At the last closing, Amyris Inc’s stock price was USD 4.21. Amyris Inc’s stock price has changed by -0.38% over the past week, -1.38% over the past month and -58.11% over the last year.

About

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells product ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-25 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BCPC Balchem Corporation

-3.47 (-2.30%)

USD4.88B 52.69 31.14
WDFC WD-40 Company

-5.75 (-2.45%)

USD3.12B 48.42 34.94
IOSP Innospec Inc

-0.66 (-0.70%)

USD2.34B 25.73 12.19
GPRE Green Plains Inc

+0.12 (+0.38%)

USD1.61B 40.40 30.98
HWKN Hawkins Inc

-0.67 (-1.74%)

USD0.81B 17.16 9.77
LWLG Lightwave Logic Inc. Common St..

-0.18 (-2.46%)

USD0.79B N/A N/A
GEVO Gevo Inc

-0.01 (-0.30%)

USD0.66B 0.30 N/A
LOOP Loop Industries Inc

+0.27 (+3.51%)

USD0.41B N/A N/A
ALTO Alto Ingredients Inc

+0.25 (+4.84%)

USD0.34B 59.60 23.88
HDSN Hudson Technologies Inc

-0.09 (-2.58%)

USD0.16B 7.59 6.91

ETFs Containing AMRS

Symbol Name Weight Mer Price(Change) Market Cap
CBDX:LSE The Medical Cannabis and .. 0.00 % 0.80 %

+0.15 (+1.65%)

N/A
FLWG:LSE Rize UCITS ICAV - Rize Me.. 0.00 % 0.65 %

+6.88 (+1.88%)

N/A
FLWR:LSE Rize UCITS ICAV - Rize Me.. 0.00 % 0.65 %

+0.12 (+2.41%)

N/A
BLUM:XETRA Rize Ucits ICAV - Rize Me.. 0.00 % 0.65 %

+0.10 (+2.18%)

USD0.04B
CBSX:XETRA Hanetf ICAV - Hanetf Alte.. 0.00 % 0.80 %

+0.15 (+1.92%)

USD0.03B
BLUM:F Rize Ucits ICAV - Rize Me.. 0.00 % 0.65 %

N/A

N/A
CBSX:F Hanetf ICAV - Hanetf Alte.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.18% 44% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.18% 44% F 22% F
Trailing 12 Months  
Capital Gain -58.11% 21% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -58.11% 21% F 21% F
Trailing 5 Years  
Capital Gain -55.00% 25% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -55.00% 25% F 15% F
Average Annual (5 Year Horizon)  
Capital Gain 84.75% 79% C+ 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 84.75% 79% C+ 92% A-
Risk Return Profile  
Volatility (Standard Deviation) 178.08% 29% F 8% F
Risk Adjusted Return 47.59% 57% F 67% D+
Market Capitalization 1.29B 75% C 71% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -7.31 75% C 72% C-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 146.66% 100% A+ 98% A+
Return on Assets -8.60% 31% F 30% F
Debt to Equity Ratio -15.23% 100% A+ 92% A-
Technical Ratios  
Short Ratio 5.95 25% F 16% F
Short Percent 20.26% 6% F 7% F
Beta 1.52 29% F 25% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.